Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,709 USD | +3,49% | +7,42% | -85,55% |
15/03 | QUOIN PHARMACEUTICALS, LTD. : Maxim herhaalt koopadvies | ZM |
14/03 | Quoin Pharmaceuticals zoekt mogelijkheden voor fusies en overnames | CI |
Omzet 2024 * | - | Omzet 2025 * | 15,58 mln. 14,58 mln. | Marktkapitalisatie | 2,53 mln. 2,36 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -9 mln. -8,42 mln. | Nettowinst (verlies) 2025 * | -9 mln. -8,42 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,16 x |
K/w-verhouding 2024 * |
-0,32
x | K/w-verhouding 2025 * |
-0,55
x | Werknemers | 4 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 26,26% |
Recentste transcriptie over Quoin Pharmaceuticals, Ltd.
1 dag | +1,88% | ||
1 week | +7,42% | ||
Lopende maand | -25,37% | ||
1 maand | -24,57% | ||
3 maanden | -81,13% | ||
6 maanden | -83,28% | ||
Lopend jaar | -85,55% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Myers
CEO | Chief Executive Officer | 62 | 05-03-18 |
Denise Carter
FOU | Founder | 55 | 05-03-18 |
Gordon Dunn
DFI | Director of Finance/CFO | 60 | 01-11-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Sember
BRD | Director/Board Member | - | 28-10-21 |
Dennis Langer
BRD | Director/Board Member | 73 | 28-10-21 |
Joseph Cooper
BRD | Director/Board Member | 66 | 28-10-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 0,709 | +3,49% | 18 132 |
29-04-24 | 0,6851 | +7,47% | 161 352 |
26-04-24 | 0,6375 | +1,19% | 56 890 |
25-04-24 | 0,63 | -0,33% | 242 254 |
24-04-24 | 0,6321 | -4,23% | 55 115 |
uitgestelde koers Nasdaq, 30 april 2024 om 17:17 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-85,55% | 2,53 mln. | |
+1,10% | 42,86 mld. | |
+12,29% | 42,74 mld. | |
+44,30% | 41,36 mld. | |
-6,20% | 27,68 mld. | |
+6,54% | 25,15 mld. | |
-23,73% | 18,63 mld. | |
+28,66% | 12,37 mld. | |
-2,85% | 11,92 mld. | |
+7,18% | 11,21 mld. |